Katrin J. Czogalla

Sigmund Freud Str. 25
Bonn, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations.

Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations.

Journal: Annals of hematology
Published: September 20, 2017

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

Journal: Blood advances
Published: March 15, 2017

Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Journal: Nature structural & molecular biology
Published: May 23, 2016

Evidence of pathogenicity of a mutation in 3' untranslated region causing mild haemophilia A.

Evidence of pathogenicity of a mutation in 3' untranslated region causing mild haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 17, 2016

VKCFD2 - from clinical phenotype to molecular mechanism.

VKCFD2 - from clinical phenotype to molecular mechanism.

Journal: Hamostaseologie
Published: June 16, 2015

Structural Modeling Insights into Human VKORC1 Phenotypes.

Structural Modeling Insights into Human VKORC1 Phenotypes.

Journal: Nutrients
Published: May 20, 2015

Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.

Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.

Journal: Thrombosis research
Published: August 22, 2014

The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.

The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.

Journal: Blood
Published: June 26, 2014

Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.

Human VKORC1 mutations cause variable degrees of 4-hydroxycoumarin resistance and affect putative warfarin binding interfaces.

Journal: Blood
Published: August 29, 2013

A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.

A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay.

Journal: Journal of thrombosis and haemostasis : JTH
Published: November 27, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026